{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:01:56Z","timestamp":1794290516324,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["2015-02733"],"award-info":[{"award-number":["2015-02733"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.eclinm.2022.101725","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T04:02:13Z","timestamp":1668139333000},"page":"101725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-3055","authenticated-orcid":false,"given":"Ricardo V.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Veiga","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mam\u00e9dio","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarissa Beatrice","family":"Zanata Petry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Lopes Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Aur\u00e9lio","family":"Schiavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Pomp\u00edlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Nogueira","family":"Quirino Pechy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Calmon da Costa Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Porto","family":"Cunha da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Paulo de Paris Caravatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"de Lima Jacy Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"da Costa Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Kuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Mantovani","family":"Sarian Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allon N.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel W.","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eclinm.2022.101725_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101725_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/M17-2640","article-title":"Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update","volume":"168","author":"Ketteler","year":"2018","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.eclinm.2022.101725_bib3","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dc11-s247","article-title":"Monitoring kidney function and albuminuria in patients with diabetes","volume":"34","author":"Heerspink","year":"2011","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.eclinm.2022.101725_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101725_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101725_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.117.032038","article-title":"Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (canagliflozin cardiovascular assessment study)","volume":"137","author":"Mahaffey","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2022.101725_bib7","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101725_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jama.2016.20563","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a Joint statement by international diabetes organizations","volume":"317","author":"Brito","year":"2017","journal-title":"JAMA"},{"issue":"966","key":"10.1016\/j.eclinm.2022.101725_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/pmj.2005.039032","article-title":"Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors","volume":"82","author":"Daousi","year":"2006","journal-title":"Postgrad Med"},{"key":"10.1016\/j.eclinm.2022.101725_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14423\/SMJ.0000000000000214","article-title":"Relation between BMI and diabetes mellitus and its complications among US older adults","volume":"108","author":"Gray","year":"2015","journal-title":"South Med J"},{"key":"10.1016\/j.eclinm.2022.101725_bib11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-016-3903-x","article-title":"Gastric bypass surgery vs. intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial","volume":"59","author":"Cummings","year":"2016","journal-title":"Diabetologia"},{"issue":"21","key":"10.1016\/j.eclinm.2022.101725_bib12","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.2013.5835","article-title":"Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomised clinical trial","volume":"309","author":"Ikramuddin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2022.101725_bib13","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101725_bib14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101725_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101725_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0420","article-title":"Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomised clinical trial","volume":"155","author":"Cohen","year":"2020","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101725_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10157-019-01842-2","article-title":"High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function","volume":"24","author":"Okubo","year":"2020","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101725_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamacardio.2017.4228","article-title":"Cardiovascular outcomes according to urinary albumin and kidney disease in patients with type 2 diabetes at high cardiovascular risk: observations from the SAVOR-TIMI 53 trial","volume":"3","author":"Scirica","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101725_bib19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101725_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/M17-2383","article-title":"Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study","volume":"169","author":"O'Brien","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2022.101725_bib21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2337\/dc16-0194","article-title":"Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery","volume":"39","author":"Coleman","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101725_bib22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2215\/CJN.07670715","article-title":"Is bariatric surgery an effective treatment for type II diabetic kidney disease?","volume":"11","author":"Friedman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101725_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013574","article-title":"Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial","volume":"7","author":"Cohen","year":"2017","journal-title":"BMJ Open"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2022.101725_bib24","first-page":"S4","article-title":"Standards of medical care in diabetes-2019","volume":"42","author":"Summary of Revisions","year":"2019","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2022.101725_bib25","first-page":"S111","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101725_bib26","first-page":"143","article-title":"Brazilian-Portuguese version of the SF-36: a reliable and valid quality of life outcome measure","volume":"39","author":"Ciconelli","year":"1999","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.eclinm.2022.101725_bib27","first-page":"dc212441","article-title":"Diabetes remission in the alliance of randomised trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D) [published online ahead of print, 2022 March 23]","author":"Kirwan","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eclinm.2022.101725_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.soard.2008.08.016","article-title":"Improvement and stabilization of chronic kidney disease after gastric bypass","volume":"5","author":"Alexander","year":"2009","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101725_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101725_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11695-018-3604-2","article-title":"National postoperative bariatric surgery outcomes in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Cohen","year":"2019","journal-title":"Obes Surg"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022004552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022004552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:20:19Z","timestamp":1781817619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022004552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"alternative-id":["S2589537022004552"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101725","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101725"}}